FDA advisory committee says common ingredient in some decongestants does not work

  • 📰 ABC7
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 68%

United States Headlines News

United States Latest News,United States Headlines

An FDA advisory committee has reviewed the effectiveness of the oral formulation of a very common nasal decongestant, phenylephrine, and found it does not work.

Walgreens pharmacy, over-the-counter medicine, cough, cold and flu relief.On Tuesday, a U.S. Food and Drug Administration advisory committee voted unanimously that the oral formulation of a very common nasal decongestant, phenylephrine, is not effective. The decision could lead to this formulation of the drug being taken off the market.

"There are certain studies that compare it to a placebo that don't show any discernible benefit," ABC News medical correspondent Dr. Darien Sutton told "Good Morning America." In a public statement Tuesday, the Consumer Healthcare Products Association, which represents manufacturers of over-the-counter-drugs, called the decision "disappointing."

While the drug's effectiveness is in question, the FDA has not raised any additional concerns about its safety. Known side effects including nervousness, jitteriness and sleeplessness, and it should be avoided or used with caution under the guidance of a doctor in people with certain health conditions including high blood pressure and glaucoma, according to the National Institutes of Health.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 67. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA approves updated Covid vaccines from Pfizer and Moderna as hospitalizations riseThe Biden administration said it expects the new Pfizer and Moderna vaccines targeting the omicron variant XBB.1.5 to be available in mid-September.
Source: CNBC - 🏆 12. / 72 Read more »

SA germ-zapping robot-maker Xenex clears major FDA hurdleThe U.S. Food and Drug Administration has granted Xenex Disinfection Services a De Novo authorization for its LightStrike+ device.
Source: ksatnews - 🏆 442. / 53 Read more »

FDA Approves Newest Covid-19 BoostersVaccine specialists say the updated shots should protect against strains now circulating. The boosters should be available within days..
Source: WSJ - 🏆 98. / 63 Read more »

FDA okays new coronavirus vaccine as respiratory illness season nearsThe covid vaccines are expected to be available later this week after the Centers for Disease Control and Prevention signs off.
Source: washingtonpost - 🏆 95. / 72 Read more »

Pfizer and Moderna updated COVID vaccines approved by FDAThe U.S. Food and Drug Administration on Monday approved updated mRNA COVID vaccines from Moderna Inc. and Pfizer Inc. People five years of age and older are...
Source: MarketWatch - 🏆 3. / 97 Read more »

FDA approves new COVID booster amid rising cases, hospitalizationsThe Food and Drug Administration approvedd new, updated COVID boosters on Monday as cases and hospitalizations rise across the United States.
Source: abc13houston - 🏆 255. / 63 Read more »